Translution Capital
@translutioncapital.com
Translution Capital is a Danish Corporate Finance house, which devises and executes innovative, customized solutions to our clients’ most challenging issues. Our services are based on extensive experience from leading Investment Banks. Our operation is independent and free of any potential conflict of interest inherent within large multi-product financial institutions. Translution Capital has engaged partnerships with a wide range of sector and product specialists ensuring a best-in-class advisory operation regardless of sector, size and situation. We operate from a platform with strong and proven reach to domestic, Nordic and international Institutional and HNI investors.
Translution Capital's Company Logos
Translution Capital's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#DDD783
Zombie
221, 215, 131
56, 57, 69
0, 3, 41, 13
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#222222
Mine Shaft
34, 34, 34
0, 0, 13
0, 0, 0, 87
About Translution Capital
Translution Capital is a Nordic Corporate Finance house that specializes in providing innovative, customized solutions to their clients' most challenging issues. With a team of experts who have extensive experience from leading Investment Banks, Translution Capital offers a range of services including strategic financial advisory, equity and debt-based fund raising, and transaction solutions. Their strategic financial advisory platform focuses on trade sales and aims to optimize value for their clients.
They prioritize confidentiality and maintaining competition during the sales process, ensuring the best possible transaction outcome. Translution Capital also devises and executes customized transaction solutions tailored to their clients' financial and strategic objectives, regardless of sector, size, or situation. With a relentless commitment to their clients, Translution Capital operates and executes auction processes with prospective investors and buyers at a high clock speed, identifying and capturing value for their clients.
Some of their selected transactions include financial advisory roles for companies such as Cessatech A/S, MME Nordic A/S, Medtrace Pharma A/S, and CombiGene AB, among others
